focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,096.00
Bid: 12,088.00
Ask: 12,092.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,090.00
High: 12,118.00
Low: 12,038.00
Prev. Close: 12,110.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Weaker pound unable to keep FTSE in green

Fri, 19th Aug 2022 12:06

(Alliance News) - London's FTSE 100 outperformed peers but was unable to stave off selling pressure in a tough session for European stocks on Friday, despite sitting just above positive territory for much of the late-morning's trade.

London's large-cap benchmark got a lift from a weaker pound, a tailwind for its overseas earners. Weakness in travel stocks and the retail sector following a poor UK confidence reading hit the index, however.

The FTSE 100 was down 8.43 points, or 0.1%, at 7,533.42. The FTSE 250 index was down 116.24 points, or 0.6%, at 20,020.41. The AIM All-Share index was down 3.52 points, or 0.4%, at 921.04.

The Cboe UK 100 index was down 0.1% at 752.79. The Cboe 250 was down 0.7% at 17,301.67. The Cboe Small Companies was down 0.1% at 14,337.79.

In Paris, the CAC 40 was down 0.8%, while the DAX 40 in Frankfurt was down 0.7%.

Stocks in New York were called lower on Friday. The Dow Jones Industrial Average was called down 0.6%, the S&P 500 was called 0.8% lower and the Nasdaq Composite down 0.9%.

Sterling quoted at USD1.1852 midday Friday, roughly a one-month low, plummeting from USD1.2000 at the London equities close on Thursday.

"The consumer backdrop feels increasingly gloomy and that's bad news because consumer spending is such an important contributor to the UK economy," AJ Bell analyst Danni Hewson commented.

"That's reflected in weakness in the pound, which is actually good news for a globally-orientated FTSE 100 as it flatters the relative value of overseas earnings."

UK retail sales defied expectations and grew on a monthly basis in July, figures on Friday showed, though they slightly missed a year-on-year forecast. On a monthly basis, sales increased 0.3% in July from June, outperforming expectations of a 0.2% decline. They had fallen 0.2% on a monthly basis in June.

UK retail sales volumes fell 3.4% on a yearly basis in July, a sharper than the FXStreet-cited market consensus of a 3.3% slide, however. In June, they had slumped 6.1% year-on-year.

Ahead of the data, a long-running UK consumer confidence tracker hit a record low.

GfK's consumer confidence index fell three points in August to minus 44, its lowest figure since records began in 1974.

Shares in London-listed retailers fell on Friday, in the wake of the poor consumer confidence reading and tricky outlook for the sector.

DIY retailer Kingfisher lost 2.3%, while high street outfits Next and JD Sports lost 1.3% and 1.4% respectively.

On AIM, Joules tumbled 36%. Scorching hot weather has hit sales of winter clothing, including "rainwear, knitwear, and wellies". Trading over the five weeks to August 14 has "softened materially," it cautioned.

Margins have taken a hit and Joules now expects a "significant loss" in its first half. It expects an improved second half, as it reaps the rewards of self-help work.

The euro stood at USD1.0057 midday Friday in London, down from USD1.0132 late Thursday. Roughly a month ago, the dollar hit parity with the single currency. Against the yen, the dollar was trading at JPY136.74, up sharply from JPY135.10.

"The US dollar and Treasury yields were supported by Fed policymakers' comments. St Louis Fed President [James] Bullard said he is leaning towards another 75 basis point increase in interest rates at next month's policy meeting while he also attempted to douse speculation of rate cuts next year," analysts at Lloyds Bank commented.

Markets are also looking towards next week's Jackson Hole Economic Symposium in Wyoming, US.

Analysts at Swiss bank UBS expect the tone from monetary policymakers to be hawkish at next week's meet.

"We anticipate a rather hawkish tone from key policymakers as they reiterate the fight against inflation is not yet over. But it's also an opportunity for Fed Chair Jerome Powell to provide more guidance on the rate path going forward, given renewed data dependency and the perception of a policy pivot. It should be noted that past Jackson Hole events have sometimes delivered surprising statements from the Fed and other central banks," UBS added.

Back in London, Just Eat Takeaway.com jumped 39%. It has relinquished a 33% stake in the iFood joint-venture to Johannesburg- and Amsterdam-listed internet assets investor Prosus for up to EUR1.8 billion.

"Just Eat Takeaway.com remains focused on improving its profitability and on a disciplined allocation of capital. It will retain the transaction proceeds to maintain its balance sheet strength and to service repayments of its upcoming debt maturities," Just Eat said.

iFood has online food and delivery operations in Latin America. Prosus and its subsidiary Movile will fully own iFood after the deal is completed. Prosus was up 0.6% in Amsterdam.

The deal comes as Just Eat Takeaway explores a deal for its Grubhub unit. Just Eat completed its USD7.3 billion acquisition of Chicago, US-headquartered Grubhub in June last year. It first mulled a sale of Grubhub in April, and on Friday said it continues to "actively explore" this.

Kingspan shares surged 6.6%, after the building materials firm said it has "been able to navigate" input cost inflation.

For the six months that ended on June 30, revenue rose 42% to EUR4.15 billion from EUR2.92 billion a year earlier. It has the first time half-year revenue topped EUR4 billion.

Pretax profit surged 30% to EUR387.6 million from EUR297.2 million.

"Despite a challenging trading environment, Kingspan delivered record half year results, with revenues over EUR4 billion for the first time. We have been able to navigate large input cost increases with only modest margin impact," Chief Executive Gene Murtagh commented.

Kingspan upped its payout by 29% to 25.6 cents from 19.9 cents.

Helping to ensure the FTSE 100 outperformed continental peers, consumer goods firms Unilever and Reckitt rose 1.0% and 1.3%.

Pharmaceutical firms were also on the up, AstraZeneca was the best blue-chip performer, up 1.4%, while GSK added 0.9%. GSK shares have slid 2.4% this week, however, having slumped 13% the week before due to worries over possible Zantac litigation.

GSK on Tuesday said a first scheduled trial in its Zantac case was voluntarily dismissed. The pharma firm noted it did not pay anything in exchange for the voluntary dismissal.

The heartburn drug was withdrawn after the US Food & Drug Administration in 2019 warned that the product contained levels of NDMA, a probable human carcinogen - a substance which has been linked to cancer.

Travel stocks were grounded amid consumer confidence fears. British Airways parent International Consolidated Airlines Group fell 2.6%, budget carrier easyJet lost 4.3% and tour operator On the Beach shed 3.8%.

Brent oil was quoted at USD94.65 a barrel midday Friday, down from USD96.12 late Thursday. Gold was quoted at USD1,750.17 an ounce, down from USD1,761.70.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.